Recombinant Mouse Proteinase-activated receptor 3 (F2rl2)

What is the molecular structure and functional classification of mouse F2rl2?

Mouse F2rl2 (Proteinase-activated receptor 3/PAR3) belongs to the protease-activated receptor family, a subfamily of seven transmembrane G protein-coupled cell surface receptors. The protein contains an extracellular N-terminus with a thrombin cleavage site, seven transmembrane domains, and an intracellular C-terminus involved in signal transduction .

Methodological approach: When investigating F2rl2 structure-function relationships, researchers should employ sequence alignment tools to compare mouse and human orthologs, focusing on the N-terminal domain where proteolytic activation occurs. Expression constructs should include the complete coding sequence (Cys29-Leu705) to maintain functional integrity .

What are the primary signaling mechanisms of F2rl2?

F2rl2 functions as a cofactor in thrombin-mediated cleavage and activation of PAR4 (F2RL3). Upon activation by proteolytic cleavage of its extracellular amino terminus, the newly exposed amino terminus acts as a tethered ligand that activates the receptor . This activation triggers phosphoinositide hydrolysis and subsequent signaling cascades through G-protein coupled pathways .

Methodological considerations: To study F2rl2 signaling, researchers should implement:

• Calcium mobilization assays to detect intracellular calcium flux

• Phosphoinositide hydrolysis measurements

• Co-expression systems with PAR4 to assess cofactor activity

• G-protein coupling analysis using GTPγS binding assays

How is F2rl2 expression regulated at the molecular level?

Recent research has identified a regulatory axis involving long non-coding RNA NEAT1, which acts as a sponge for miR-582-5p that directly targets F2rl2. In myocardial infarction models, NEAT1 and F2rl2 are highly expressed while miR-582-5p is downregulated .

Methodological approach: For investigating F2rl2 expression regulation:

• Use the validated primers shown in Table 1 for precise qRT-PCR quantification

• Employ dual-luciferase reporter assays to verify miRNA binding sites

• Implement RNA immunoprecipitation to confirm RNA-protein interactions

• Utilize gain/loss-of-function approaches with shRNA or overexpression vectors

What expression systems are optimal for producing recombinant mouse F2rl2?

Recombinant F2rl2 production requires consideration of proper folding and post-translational modifications essential for functionality.

Methodological approach: Based on available data, researchers should consider:

• Mammalian expression systems (HEK293 cells) for proper folding and glycosylation

• E. coli systems for producing specific domains (with limitations on functionality)

• C-terminal tagging strategies (6-His tag) to facilitate purification without disrupting the critical N-terminal region

• Serum-free formulations for applications requiring carrier-free preparations

When expressing F2rl2, verify protein integrity through Western blot analysis using validated antibodies (e.g., ab40769, Abcam, 1:500 dilution) .

What are the validated protocols for detecting F2rl2 expression in mouse tissues?

For accurate detection and quantification of F2rl2:

Methodological recommendations:

• RNA extraction using standardized protocols followed by qRT-PCR with validated primers (see Table 1)

• Protein detection via Western blot using RIPA lysis solution for extraction, followed by BCA protein quantification

• Load 20 μg protein per lane with GAPDH (ab181602, 1:5000) as loading control

• For tissue samples, develop standardized collection and processing protocols to minimize degradation

What signaling pathways and protein interaction networks involve F2rl2?

F2rl2 participates in several important signaling networks:

Methodological approach: For pathway analysis, researchers should:

• Implement phosphoproteomic analysis to identify phosphorylation cascades

• Use specific pathway inhibitors to delineate signaling branches

• Perform co-immunoprecipitation to identify direct protein interaction partners

• Consider systems biology approaches to map comprehensive signaling networks

How does F2rl2 contribute to myocardial infarction pathophysiology?

F2rl2 plays a significant role in myocardial infarction (MI) pathology. Downregulation of F2rl2 has been shown to ameliorate left ventricular function, reduce infarct area, and decrease cell apoptosis in MI mouse models .

Methodological approach for MI studies:

• Establish MI mouse models following standardized surgical procedures

• Assess cardiac function via echocardiography, measuring left ventricular ejection fraction (EF) and fractional shortening (FS)

• Evaluate infarct size using triphenyltetrazolium chloride and Evans blue staining

• Analyze tissue pathology with hematoxylin-eosin staining

• Quantify apoptosis using TUNEL assay

• For in vitro studies, implement oxygen-glucose deprivation models using human cardiac myocytes

What is the role of the NEAT1/miR-582-5p/F2rl2 regulatory axis in cardiac pathology?

The regulatory network involving NEAT1, miR-582-5p, and F2rl2 has emerged as an important mechanism in myocardial infarction:

Methodological approach:

• NEAT1 acts as a molecular sponge for miR-582-5p, which targets F2rl2

• Silencing NEAT1 increases miR-582-5p levels and decreases F2rl2 expression

• This intervention improves cardiac parameters in MI models

• Validation requires dual-luciferase reporter assays to confirm direct interactions

• Gain/loss-of-function studies should manipulate each component of the axis individually

What are the challenges in developing specific modulators for mouse F2rl2?

Developing selective F2rl2 modulators presents several challenges:

Methodological considerations:

• The high structural similarity between PAR family members requires precise targeting

• The unique activation mechanism involving proteolytic cleavage complicates traditional drug design approaches

• Species differences between mouse and human orthologs must be considered for translational research

• Both orthosteric (binding at the active site) and allosteric (binding at secondary sites) approaches should be explored

• Validation requires demonstrating specificity against other PAR family members

How should researchers design gain/loss-of-function studies for F2rl2?

For functional studies of F2rl2:

Methodological approach:

• For knockdown experiments, use validated shRNA approaches as demonstrated in MI studies

• Verify knockdown efficiency at both mRNA and protein levels

• Include appropriate controls (e.g., shNC) in all experiments

• For overexpression studies, consider inducible systems to control expression levels

• In vivo delivery can be achieved through lentiviral vectors injected directly into target tissues

• Phenotypic assessment should include both molecular markers and functional outcomes